These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28747069)

  • 41. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey.
    Iba T; Nisio MD; Levy JH; Kitamura N; Thachil J
    BMJ Open; 2017 Sep; 7(9):e017046. PubMed ID: 28963294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
    Iba T; Saitoh D; Wada H; Asakura H
    Crit Care; 2014 Sep; 18(5):497. PubMed ID: 25220851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antithrombin III for early diagnosis of DIC in sepsis patients: a retrospective analysis with 445 patients].
    Xu Y; Zhu R; Sun Y; Li X; Ma X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):127-132. PubMed ID: 28625259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC.
    Wada H; Gabazza EC; Asakura H; Koike K; Okamoto K; Maruyama I; Shiku H; Nobori T
    Am J Hematol; 2003 Sep; 74(1):17-22. PubMed ID: 12949885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
    Taylor FB; Wada H; Kinasewitz G
    Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modified score for disseminated intravascular coagulation in the critically ill.
    Sivula M; Tallgren M; Pettilä V
    Intensive Care Med; 2005 Sep; 31(9):1209-14. PubMed ID: 15959760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Markers of Inflammation and Infection in Sepsis and Disseminated Intravascular Coagulation.
    Patel P; Walborn A; Rondina M; Fareed J; Hoppensteadt D
    Clin Appl Thromb Hemost; 2019; 25():1076029619843338. PubMed ID: 30991817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma: comparison with acute coagulopathy of trauma-shock.
    Yanagida Y; Gando S; Sawamura A; Hayakawa M; Uegaki S; Kubota N; Homma T; Ono Y; Honma Y; Wada T; Jesmin S
    Surgery; 2013 Jul; 154(1):48-57. PubMed ID: 23684364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
    Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Saitoh D; Gando S; Thachil J
    Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
    Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
    Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can advanced hemostatic parameters detect disseminated intravascular coagulation more accurately in patients with cirrhosis of the liver?
    Ho CH; Hou MC; Lin HC; Lee SD; Liu SM
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jun; 61(6):332-8. PubMed ID: 9684509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury.
    Kowal-Vern A; Walenga JM; Hoppensteadt D; Gamelli RL
    J Burn Care Res; 2013; 34(4):459-64. PubMed ID: 23202877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure.
    Kuroda H; Masuda Y
    Clin Appl Thromb Hemost; 2020; 26():1076029620981630. PubMed ID: 33332196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Designing the Diagnostic Criteria for Disseminated Intravascular Coagulation (DIC).
    Thachil J; Iba T
    Juntendo Iji Zasshi; 2023; 69(6):463-465. PubMed ID: 38855069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the International Society on Thrombosis and Haemostasis and institutional diagnostic criteria of disseminated intravascular coagulation in pediatric patients.
    Soundar EP; Jariwala P; Nguyen TC; Eldin KW; Teruya J
    Am J Clin Pathol; 2013 Jun; 139(6):812-6. PubMed ID: 23690126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.
    Kienast J; Juers M; Wiedermann CJ; Hoffmann JN; Ostermann H; Strauss R; Keinecke HO; Warren BL; Opal SM;
    J Thromb Haemost; 2006 Jan; 4(1):90-7. PubMed ID: 16409457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
    Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.